Abstract:BACKGROUND:How the gut microbiota regulates intestinal homeostasis is not completely clear. Gut microbiota metabolite short-chain fatty acids (SCFAs) have been reported to regulate T-cell differentiation. However, the mechanisms underlying SCFA regulation of T-cell differentiation and function remain to be investigated.METHODS:CBir1, an immunodominant microbiota antigen, transgenic T cells were treated with butyrate under various T-cell polarization conditions to investigate butyrate regulation of T-cell differentiation and the mechanism involved. Transfer of butyrate-treated CBir T cells into Rag1-/- mice was performed to study the in vivo role of such T cells in inducing colitis.RESULTS:Although butyrate promoted Th1 cell development by promoting IFN-γ and T-bet expression, it inhibited Th17 cell development by suppressing IL-17, Rorα, and Rorγt expression. Interestingly, butyrate upregulated IL-10 production in T cells both under Th1 and Th17 cell conditions. Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1. Rag1-/- mice transferred with butyrate-treated T cells demonstrated less severe colitis, compared with transfer of untreated T cells, and administration of anti-IL-10R antibody exacerbated colitis development in Rag-/- mice that had received butyrate-treated T cells. Mechanistically, the effects of butyrate on the development of Th1 cells was through inhibition of histone deacetylase but was independent of GPR43.CONCLUSIONS:These data indicate that butyrate controls the capacity of T cells in the induction of colitis by differentially regulating Th1 and Th17 cell differentiation and promoting IL-10 production, providing insights into butyrate as a potential therapeutic for the treatment of inflammatory bowel disease.

Short chain fatty acids regulation of neutrophil production of IL-10

Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells’ Differentiation and Function in Induction of Colitis

Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease

Short chain fatty acids regulate T cell metabolism to promote IL-22 production and gut immunity

Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity

Bacterial short‐chain fatty acid metabolites modulate the inflammatory response against infectious bacteria

Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis

Regulation of short-chain fatty acids in the immune system

Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance

Regulation of inflammation by short chain fatty acids

Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils

GPR43 Mediates Microbiota Metabolite SCFA Induction of Antimicrobial Peptide Expression in Intestinal Epithelial Cells Via Activation of Mtor and STAT3

Short-chain fatty acids: linking diet, the microbiome and immunity

Butyrate Prevents the Pathogenic Anemia‐Inflammation Circuit by Facilitating Macrophage Iron Export

Research progress on the roles of short chain fatty acids in intestinal mucosa homeostasis immune regulation

Dysregulation of CD177+ neutrophils on intraepithelial lymphocytes exacerbates gut inflammation via decreasing microbiota-derived DMF

Regulation of immune cell function by short-chain fatty acids

Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases

G Protein-Coupled Receptor 43 Modulates Neutrophil Recruitment during Acute Inflammation

Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate